Table 2.
Summary of Arterial Embolization Procedures for the Management of Insulinoma (Until December 2023)
| Reference | No. of cases | Age (y) | Gender | Tumor size (mm) | Tumor location | Reason for the choice of treatment | No. of treatments | Postprocedure complications | Follow-up (mo) | Recurrence | Time of recurrence (mo) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Moore 8 | 1 | 38 | F | 20 | H | SF | 1 | Low back pain, nausea, Increase in liver enzymes | 11 | No | - |
| Uflacker 13 | 2 | 56/49 | M/M | 18/20 | H/B | SR/SE | 2/1 | Abdominal pain, hyperamylasaemia/none | 18/40 | No | - |
| Rott 14 | 1 | 84 | F | 14 | H | SR | 1 | Mild pancreatitis and pain, transitory mild diabetes | 12 | No | - |
| Peppa 11 | 1 | 30 | M | 30 | PP | DR | 1 | Abdominal pain | 12 | Yes | 12 |
| Balawejder 15 | 1 | 48 | F | 22 | UP | SR | 1 | None | N/A | Yes | 5 |
| Mele 2 | 1 | 72 | F | 17 | H | C | 2 | Mild pancreatitis and pain | 108 | Yes | 48 |
| Donohoe 9 | 2 | 83/53 | M/M | 32/NR | UP/UP | C/SR | 1/1 | None/none | 1/1 | No/No | - |
| Our case | 1 | 80 | M | 37 | H, UP | SR, C | 1 | None | 5 | No | - |
| Total | 10 | 59,3 ± 19,3 | 6 M/4 F | 23,3 ± 7,7 | H = 5; B = 1; UP = 4; PP = 1 | SR = 5; C = 3; SF = 1; SE = 1; DR = 1 | 1 in 8 cases | None in 5 cases | 23,1 ± 33,9 | 3 (30%) | 22 ± 23 |
Abbreviations: B = body; C = comorbidities; DR = disease recurrence; H = head; NR = no report; PP = peripancreatic; SE = surgical emergency; SF = surgical failure; SR = surgery refusal; UP = uncinate process.
Cumulative data are indicated as mean ± SD, and as absolute values with percentages in parentheses.
Source: Own elaboration.